Subvenciones y ayudas para entidades sociales

13914
convocatorias abiertas
9
países
12
fuentes oficiales

Reunimos en un solo lugar las convocatorias públicas de subvenciones de España, la Unión Europea y otros países. Cada ficha indica el importe, el plazo real y quién puede solicitarla, para que sepas de un vistazo si tu entidad encaja.

Subvenciones por tipo de entidad

Convocatorias abiertas

13.914 convocatorias · ordenadas por Cierran antes

🇺🇸Estados UnidosABIERTA
204 días

High Priority HIV and Substance Use Research (RM1 Clinical Trial Optional)

Estados Unidos · US

Quién puede pedirla Native American tribal governments (Federally recognized) · Public housing authorities/Indian housing authorities · Small businesses · Independent school districts · Private institutions of higher education · County governments · State governments · For profit organizations other than small businesses · Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education · Special district governments · City or township governments · Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education · Public and State controlled institutions of higher education · Others (see text field entitled "Additional Information on Eligibility" for clarification) · Native American tribal organizations (other than Federally recognized tribal governments)

The purpose of this Funding Opportunity Announcement (FOA) is to support high priority research at the intersection of HIV and substance use. This FOA invites innovative research projects with the potential to open new areas of HIV/AIDS research and/or lead to new avenues for prevention, treatment and cure of HIV among people who use drugs (PWUD). Applications submitted under this FOA are required to have a detailed research plan, preliminary data, and a clear description of the nexus with substance use. This FOA is open to both individual researchers and research teams and includes all areas of research from basic science to clinical and implementation research. All studies must focus on NIH HIV/AIDS Research Priorities: NOT-OD-20-018: UPDATE: NIH HIV/AIDS Research Priorities and Guidelines for Determining HIV/AIDS Funding.

1.500.000 US$5/3/2027
Ver
🇺🇸Estados UnidosABIERTA
205 días

Opportunities for Collaborative Research at the NIH Clinical Center (U01 Clinical Trial Optional)

Estados Unidos · US

Quién puede pedirla Native American tribal organizations (other than Federally recognized tribal governments) · Private institutions of higher education · Small businesses · Others (see text field entitled "Additional Information on Eligibility" for clarification) · Public and State controlled institutions of higher education · Public housing authorities/Indian housing authorities · Independent school districts · Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education · Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education · For profit organizations other than small businesses · State governments · City or township governments · Special district governments · Native American tribal governments (Federally recognized) · County governments

The goal of this program is to support collaborative translational research projects aligned with NIH efforts to enhance the translation of basic biological discoveries into clinical applications that improve health. It encourages high quality science demonstrating the potential to result in understanding an important disease process or lead to new therapeutic interventions, diagnostics, or prevention strategies within the research interests and priorities of the participating NIH Institutes/Centers (ICs).Specifically, the program seeks to broaden and strengthen translational research collaborations between basic and clinical researchers both within and outside NIH to accelerate and enhance translational science by promoting partnerships between NIH intramural investigators (e.g., those conducting research within the labs and clinics of the NIH) and extramural investigators (e.g., those conducting research in labs outside the NIH), and by providing support for extramural investigators to take advantage of the unique research opportunities available at the NIH Clinical Center by conducting clinical research projects in collaboration with NIH intramural investigators.

500.000 US$6/3/2027
Ver
🇺🇸Estados UnidosABIERTA
205 días

High Priority HIV and Substance Use Research (R01 Clinical Trial Optional)

Estados Unidos · US

Quién puede pedirla City or township governments · Small businesses · Special district governments · Public housing authorities/Indian housing authorities · County governments · State governments · Others (see text field entitled "Additional Information on Eligibility" for clarification) · Public and State controlled institutions of higher education · For profit organizations other than small businesses · Independent school districts · Native American tribal governments (Federally recognized) · Native American tribal organizations (other than Federally recognized tribal governments) · Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education · Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education · Private institutions of higher education

The purpose of this Funding Opportunity Announcement (FOA) is to support high priority research at the intersection of HIV and substance use. This FOA invites innovative research projects with the potential to open new areas of HIV/AIDS research and/or lead to new avenues for prevention, treatment and cure of HIV among people who use drugs (PWUD). Applications submitted under this FOA are required to have a detailed research plan, preliminary data, and a clear description of the nexus with substance use. This FOA is open to both individual researchers and research teams and includes all areas of research from basic science to clinical and implementation research. All studies must focus on NIH HIV/AIDS Research Priorities: NOT-OD-20-018: UPDATE: NIH HIV/AIDS Research Priorities and Guidelines for Determining HIV/AIDS Funding.

Según convocatoria6/3/2027
Ver
🇺🇸Estados UnidosABIERTA
207 días

Programa de Indemnización Internacional de Artes y Artefactos de la NEA 2, FY2027 (27/3)

Estados Unidos · US

Quién puede pedirla County governments · State governments · Public and State controlled institutions of higher education · Independent school districts · Special district governments · Native American tribal governments (Federally recognized) · Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education · City or township governments · Private institutions of higher education

Consulte las pautas e instrucciones de la solicitud en arts.gov para obtener más información.

100.000 US$8/3/2027
Ver
🇺🇸Estados UnidosABIERTA
209 días

Continuation of the Cardiovascular Repository for-Type 1 Diabetes (CARE-T1D) Consortium U01 (Open Competition)- Research (U01, Clinical Trial Not Allowed)

Estados Unidos · US

Quién puede pedirla State governments · Native American tribal organizations (other than Federally recognized tribal governments) · Private institutions of higher education · For profit organizations other than small businesses · County governments · Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education · Others (see text field entitled "Additional Information on Eligibility" for clarification) · Native American tribal governments (Federally recognized) · Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education · Public housing authorities/Indian housing authorities · Small businesses · Special district governments · Independent school districts · City or township governments · Public and State controlled institutions of higher education

The NIH Cardiovascular Repository for Type 1 Diabetes (CaRe-T1D) was created to improve research on type 1 diabetes (T1D) and cardiovascular disease (CVD). Cardiovascular complications remain the top cause of death among people with T1D and greatly shorten lifespan. The mechanisms underlying atherosclerosis, cardiomyopathy, endothelial dysfunction, and cardiac autonomic neuropathy in T1D remain poorly understood. While managing traditional risk factors—such as high blood glucose, high blood pressure, and elevated cholesterol lower cardiovascular risk, a significant residual risk remains even with optimal control. In addition to atherosclerosis, both diastolic and systolic diabetic cardiomyopathy play a major role in morbidity and mortality among these patients. Currently, no therapies are specifically approved to prevent or treat these common and severe cardiovascular issues in T1D. The purpose of this NOFO is to promote collaborative and interdisciplinary research aimed at enhancing the understanding of the development of CVD in individuals with T1D and the differences with CVD in T1D by continuing the efforts of the CaRe-T1D consortium.This NOFO is associated with the Special Diabetes Program (https://www.niddk.nih.gov/about-niddk/research-areas/diabetes/type-1-diabetes-special-statutory-funding-program/about-special-diabetes-program) which funds research on the prevention, treatment, and cure of type 1 diabetes and its complications, including unique, innovative, and collaborative research consortia and clinical trials networks.

500.000 US$10/3/2027
Ver
🇪🇺Unión EuropeaPRÓXIMA
210 días

Pillar I: Facilitating development of institutional open access policies through the retention of intellectual property rights

Unión Europea · EU

Pillar I: Facilitating development of institutional open access policies through the retention of intellectual property rights

2.000.000 €11/3/2027

Ejecución: 8/12/2026

Ver
🇪🇺Unión EuropeaPRÓXIMA
210 días

Pillar II: Talent ecosystems for attractive early research careers

Unión Europea · EU

Pillar II: Talent ecosystems for attractive early research careers

2.000.000 €11/3/2027

Ejecución: 8/12/2026

Ver
🇪🇺Unión EuropeaPRÓXIMA
210 días

Pilar III: La ciencia llega a la ciudad 2029

Unión Europea · EU

Pilar III: La ciencia llega a la ciudad 2029

2.000.000 €11/3/2027

Ejecución: 8/12/2026

Ver
🇪🇺Unión EuropeaPRÓXIMA
210 días

Pilar III: Promoción de la participación pública en I+I y la alfabetización científica

Unión Europea · EU

Pilar III: Promoción de la participación pública en I+I y la alfabetización científica

2.000.000 €11/3/2027

Ejecución: 8/12/2026

Ver
🇪🇺Unión EuropeaPRÓXIMA
210 días

Pillar IV: Upgrading the EU’s independent knowledge on China's Science, Technology and Innovation system

Unión Europea · EU

Pillar IV: Upgrading the EU’s independent knowledge on China's Science, Technology and Innovation system

2.000.000 €11/3/2027

Ejecución: 8/12/2026

Ver
🇩🇪AlemaniaABIERTA
214 días

Financiación de proyectos de investigación "Plataforma de Privacidad - La seguridad de TI protege la privacidad y apoya la democracia"

Alemania · DE

Si investiga los desafíos del uso responsable de la tecnología digital, puede recibir una subvención bajo ciertas condiciones.

Según convocatoria14/3/2027
Ver
🇺🇸Estados UnidosABIERTA
215 días

Development and Testing of Novel Interventions to Improve HIV Prevention, Treatment, and Program Implementation for People Who Use Substances (R34 Clinical Trial Required)

Estados Unidos · US

Quién puede pedirla Private institutions of higher education · Native American tribal governments (Federally recognized) · Native American tribal organizations (other than Federally recognized tribal governments) · Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education · Public and State controlled institutions of higher education · Special district governments · State governments · Public housing authorities/Indian housing authorities · Small businesses · City or township governments · Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education · Others (see text field entitled "Additional Information on Eligibility" for clarification) · For profit organizations other than small businesses · Independent school districts · County governments

This notice of funding opportunity (NOFO) encourages formative research, intervention development, and pilot-testing of interventions. Primary scientific areas of focus include the feasibility, tolerability, acceptability and safety of novel or adapted interventions that target HIV prevention, treatment or services research for people who use drugs. For the purposes of this NOFO, "intervention" may include behavioral, social, or structural approaches, as well as combination biomedical and behavioral approaches that prevent the acquisition and transmission of HIV infection, or improve clinical outcomes for persons living with HIV.

Según convocatoria16/3/2027
Ver
🇪🇺Unión EuropeaPRÓXIMA
217 días

New approaches for decentralized, federated and sustainable AI data processing (RIA)

Unión Europea · EU

New approaches for decentralized, federated and sustainable AI data processing (RIA)

2.000.000 €18/3/2027

Ejecución: 17/11/2026

Ver
🇪🇺Unión EuropeaPRÓXIMA
217 días

Demand-side 3C pilot demonstrators on converged Telco Edge Cloud Infrastructure (IA)

Unión Europea · EU

Demand-side 3C pilot demonstrators on converged Telco Edge Cloud Infrastructure (IA)

2.000.000 €18/3/2027

Ejecución: 17/11/2026

Ver
🇪🇺Unión EuropeaPRÓXIMA
217 días

Energy efficiency and sustainability of AI data processing in Data Centres (IA)

Unión Europea · EU

Energy efficiency and sustainability of AI data processing in Data Centres (IA)

2.000.000 €18/3/2027

Ejecución: 17/11/2026

Ver
🇪🇺Unión EuropeaPRÓXIMA
217 días

Apply AI: Challenge-Driven AI Innovation Booster in Apply AI prioritised sectors (RIA) (Partnership in AI, Data and Robotics)

Unión Europea · EU

Apply AI: Challenge-Driven AI Innovation Booster in Apply AI prioritised sectors (RIA) (Partnership in AI, Data and Robotics)

2.000.000 €18/3/2027

Ejecución: 17/11/2026

Ver
🇪🇺Unión EuropeaPRÓXIMA
217 días

Apply AI: AI-Driven Robotics for Industry: Enabling System Integration and Adoption (IA) (Partnership in AI, Data and Robotics)

Unión Europea · EU

Apply AI: AI-Driven Robotics for Industry: Enabling System Integration and Adoption (IA) (Partnership in AI, Data and Robotics)

2.000.000 €18/3/2027

Ejecución: 17/11/2026

Ver
🇪🇺Unión EuropeaPRÓXIMA
217 días

International cooperation in AI (IA)

Unión Europea · EU

International cooperation in AI (IA)

2.000.000 €18/3/2027

Ejecución: 17/11/2026

Ver
🇪🇺Unión EuropeaPRÓXIMA
217 días

Horizon scanning and foresight in future enabling digital technologies (CSA)

Unión Europea · EU

Horizon scanning and foresight in future enabling digital technologies (CSA)

2.000.000 €18/3/2027

Ejecución: 17/11/2026

Ver
🇪🇺Unión EuropeaPRÓXIMA
217 días

EU Frontier AI Initiative: Developing frontier AI solutions that are safe and computationally efficient within Apply AI (RIA)

Unión Europea · EU

EU Frontier AI Initiative: Developing frontier AI solutions that are safe and computationally efficient within Apply AI (RIA)

2.000.000 €18/3/2027

Ejecución: 17/11/2026

Ver
🇪🇺Unión EuropeaPRÓXIMA
217 días

Advanced and Innovative hardware components for Virtual Worlds (RIA) (Virtual Worlds Partnership)

Unión Europea · EU

Advanced and Innovative hardware components for Virtual Worlds (RIA) (Virtual Worlds Partnership)

2.000.000 €18/3/2027

Ejecución: 17/11/2026

Ver
🇪🇺Unión EuropeaPRÓXIMA
217 días

Create a thriving and competitive Virtual Worlds and Web 4.0 ecosystem (CSA) (Virtual Worlds Partnership)

Unión Europea · EU

Create a thriving and competitive Virtual Worlds and Web 4.0 ecosystem (CSA) (Virtual Worlds Partnership)

2.000.000 €18/3/2027

Ejecución: 17/11/2026

Ver
🇪🇺Unión EuropeaPRÓXIMA
217 días

Facilitate the engagement of European stakeholders in international digital standardisation (CSA)

Unión Europea · EU

Facilitate the engagement of European stakeholders in international digital standardisation (CSA)

2.000.000 €18/3/2027

Ejecución: 17/11/2026

Ver
🇪🇺Unión EuropeaPRÓXIMA
217 días

Advanced integrated photonic devices for extended features and ultra-low power consumption (RIA) (Photonics Partnership)

Unión Europea · EU

Advanced integrated photonic devices for extended features and ultra-low power consumption (RIA) (Photonics Partnership)

2.000.000 €18/3/2027

Ejecución: 17/11/2026

Ver

Comprueba si tu entidad puede optar

Crea tu perfil y Captaru puntúa cada convocatoria según tu entidad, tu sector y tu territorio. Además te ayuda a redactar la solicitud.